13Jan/14

Zebra Biologics Launched to Commercialize Ground-Breaking Next Gen … – 4-traders (press release)

Zebra Biologics Launched to Commercialize Ground-Breaking Next Gen
4-traders (press release)
Zebra’s mission is the commercialization of human therapeutic antibodies derived by a novel approach that allows the generation and selection of both agonist and antagonist antibodies from functional screens using a modified combinatorial library approach.
Zebra Biologics launches in SDSan Diego Source (subscription)

all 5 news articles »

13Jan/14

Zebra Biologics Launched to Commercialize Ground-Breaking Next Gen … – Business Wire (press release)

Zebra Biologics Launched to Commercialize Ground-Breaking Next Gen
Business Wire (press release)
Zebra’s mission is the commercialization of human therapeutic antibodies derived by a novel approach that allows the generation and selection of both agonist and antagonist antibodies from functional screens using a modified combinatorial library approach.

and more »

13Jan/14

Anjali Devi's organs to be donated to a medical college – Newstrack India


AEG India

Anjali Devi’s organs to be donated to a medical college
Newstrack India
Chennai, Jan 13 (IANS) The vital organs of veteran Telugu actress Anjali Devi, who died here Monday, will be donated to Sri Ramachandra Media College (SRMC). She was 86. “Her body has already been shifted to SRMC. She wanted her organs to be 
Senior Tollywood Actress Anjali Devi Died in ChennaiAEG India

all 31 news articles »

13Jan/14

US FDA Accepts New Drug Application for Gilead's Idelalisib for the Treatment … – Investor's Business Daily


Drug Discovery & Development

US FDA Accepts New Drug Application for Gilead’s Idelalisib for the Treatment
Investor’s Business Daily
The NDA for iNHL, submitted on September 11, 2013, was supported by a single arm Phase 2 study (Study 101-09) evaluating idelalisib in patients with iNHL that is refractory (non-responsive) to rituximab and to alkylating-agent-containing chemotherapy.
FDA Accepts NDA for Gilead Lymphoma DrugDrug Discovery & Development

all 6 news articles »